L(+)-Ornithine hydrochloride
Names
[ CAS No. ]:
3184-13-2
[ Name ]:
L(+)-Ornithine hydrochloride
[Synonym ]:
L-Ornithine, monohydrochloride
H-Orn-OH.HCl
L-Orn hydrochloride
(2S)-2,5-diaminopentanoic acid hydrochloride
L-Ornithine monohydrochloride
L-Ornithine HCl
(S)-2,5-Diaminovaleric acid monohydrochloride
D-ORNITHINE HCL
L(+)-Ornithinehydrochloride
H-Orn-OH·HCl
(S)-2,5-Diaminopentanoic acid monohydrochloride
D-ORN,HCL
MFCD00012917
H-D-ORN HCL
L-ORN HCL
ORNITHINE HCL
L(+)-Ornithine Hydrochloride
L-Ornithine hydrochloride (1:1)
H-L-ORN-OH HCL
Z3YZVQ &&L or S Form HCl
(S)-(+)-2,5-Diaminopentanoic acid hydrochloride
H-D-ORN-OH HCL
(S)-2,5-Diaminopentanoic acid hydrochloride
L-Ornithine, hydrochloride (1:1)
EINECS 240-729-3
L-ornithine hydrochloride
Guanine Hydrochloride
Biological Activity
[Description]:
[Related Catalog]:
[Target]
Human Endogenous Metabolite
[References]
[Related Small Molecules]
Chemical & Physical Properties
[ Density]:
1.57
[ Boiling Point ]:
308.7ºC at 760 mmHg
[ Melting Point ]:
245 °C (dec.)(lit.)
[ Molecular Formula ]:
C5H13ClN2O2
[ Molecular Weight ]:
168.622
[ Flash Point ]:
140.5ºC
[ Exact Mass ]:
168.066559
[ PSA ]:
89.34000
[ LogP ]:
1.33980
[ Index of Refraction ]:
24 ° (C=4, 6mol/L HCl)
MSDS
Toxicological Information
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- RM2985000
- CHEMICAL NAME :
- Ornithine, monohydrochloride, L-
- CAS REGISTRY NUMBER :
- 3184-13-2
- LAST UPDATED :
- 199701
- DATA ITEMS CITED :
- 3
- MOLECULAR FORMULA :
- C5-H12-N2-O2.Cl-H
- MOLECULAR WEIGHT :
- 168.65
- WISWESSER LINE NOTATION :
- Z3YZVQ &GH -L
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 10 gm/kg
- TOXIC EFFECTS :
- Behavioral - altered sleep time (including change in righting reflex) Behavioral - ataxia Lungs, Thorax, or Respiration - dyspnea
- REFERENCE :
- JPMSAE Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- Volume(issue)/page/year: 62,49,1973 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X4776 No. of Facilities: 162 (estimated) No. of Industries: 2 No. of Occupations: 6 No. of Employees: 2955 (estimated) No. of Female Employees: 2312 (estimated)
Safety Information
[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
[ Hazard Codes ]:
Xi
[ Risk Phrases ]:
R36/37/38
[ Safety Phrases ]:
S24/25
[ RIDADR ]:
NONH for all modes of transport
[ WGK Germany ]:
3
[ RTECS ]:
RM2985000
[ HS Code ]:
2922499990
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Preparation
Customs
[ HS Code ]: 2922499990
[ Summary ]:
HS:2922499990 other amino-acids, other than those containing more than one kind of oxygen function, and their esters; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward) MFN tariff:6.5% General tariff:30.0%
Articles
Am. J. Respir. Cell. Mol. Biol. 48(6) , 694-702, (2013)
Up-regulation of arginase contributes to airways hyperresponsiveness (AHR) in asthma by reducing L-arginine bioavailability for the nitric oxide (NO) synthase isozymes. The product of arginase activit...
Microbacterium kyungheense sp. nov. and Microbacterium jejuense sp. nov., isolated from salty soil.Int. J. Syst. Evol. Microbiol. 64(Pt 7) , 2267-73, (2014)
Two novel strains, THG-C26(T) and THG-C31(T), were characterized using a polyphasic approach to determine their taxonomic positions. These two isolates were aerobic, Gram-stain-positive, non-motile, n...
Treatment of arginase deficiency revisited: guanidinoacetate as a therapeutic target and biomarker for therapeutic monitoring.Dev. Med. Child Neurol. 56(10) , 1021-4, (2014)
Hyperargininaemia is a disorder of the last step of the urea cycle. It is an autosomal recessive disease caused by deficiency of liver arginase-1 and usually presents later in childhood with progressi...